Alibaba Adds Embedded CPU Core Designer
Junko Yoshida, EETimes
4/20/2018 03:31 PM EDT
MADISON, Wis. — China’s internet behemoth, Alibaba Group, announced on Friday the acquisition of C-Sky Microsystems, a designer of China’s home-grown 32-bit embedded CPU processing core.
Alibaba did not disclose terms of the acquisition.
The move underscores a growing trend among companies, such as Google, Amazon, and Alibaba, who are eager to swallow up chip companies with a goal to design chips that fit their businesses.
As EE Times reported last year, even well before this acquisition was announced, C-Sky enjoyed a unique tie with Alibaba. As Xiaoning Qi, CEO of C-Sky, explained then, C-Sky was already the first chip company in the world to receive a sizable investment from Alibaba. C-Sky was founded in Hangzhou in 2001.
|
|
E-mail This Article |
|
Printer-Friendly Page |
Related News
- Alibaba Fuels China's CPU Gambit
- ChipX Introduces Synthesizable 32-Bit CPU With Best-in-Class Code Density for Embedded and Consumer Applications
- Renesas Introduces Industry's First General-Purpose 32-bit RISC-V MCUs with Internally Developed CPU Core
- Renesas Unveils the First Generation of Own 32-bit RISC-V CPU Core Ahead of Competition
- Renesas Selects Andes RISC-V 32-Bit CPU Cores for its First RISC-V Implementation of ASSPs
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design






